Interaction of human recombinant tumor necrosis factor-related apoptosis-inducing ligand and osteoprotegerin could contribute to enhancement of the erosive processes induced by human synovial cells.
Narducci
Paola
P
Bareggi
Renato
R
Nicolin
Vanessa
V
D001172:Arthritis, Rheumatoid / Q000378:metabolism* / Q000473:pathology*; D002478:Cells, Cultured; D004347:Drug Interactions; D005347:Fibroblasts / Q000187:drug effects / Q000473:pathology*; D006801:Humans; D053244:Osteoprotegerin / Q000378:metabolism* / Q000494:pharmacology; D011994:Recombinant Proteins / Q000378:metabolism / Q000494:pharmacology; D013583:Synovial Membrane / Q000473:pathology; D053221:TNF-Related Apoptosis-Inducing Ligand / Q000378:metabolism* / Q000494:pharmacology
D053244:Osteoprotegerin; D011994:Recombinant Proteins; D053221:TNF-Related Apoptosis-Inducing Ligand; C505653:TNFSF10 protein, human